Dagens

Nyheter

Håll dig informerad om senaste utveckling och framsteg från TRICALS. Här rapporterar vi om våra framsteg och insatserna från våra omfattande samarbeten. Bläddra och läs de senaste nyheterna för att hålla dig uppdaterat längs vår resa mot att hitta en behandling för ALS.

Measuring treatment effects based on patient preference
Measuring treatment effects based on patient preference
To evaluate the effect of an investigational drug in ALS clinical trials,…
Håll [u]kontakten[/u]

Håll kontakten

Vill du hålla dig uppdaterad med de senaste nyheterna från TRICALS? Klicka på knappen nedan för att prenumerera på vårt nyhetsbrev

TRICALS Enrols First Participants in Phase 3 MAGNET platform trial for ALS
TRICALS Enrols First Participants in Phase 3 MAGNET platform trial for ALS
TRICALS (the Treatment Research Initiative to Cure ALS), in collaboration with ALS…
USA: new law promises $100 million for ALS research
USA: new law promises $100 million for ALS research
A new law has been passed in the United States to give…
Congratulations to our TRICALS colleagues as UK Government invests £50 million to find a cure for ALS
Congratulations to our TRICALS colleagues as UK Government invests £50 million to find a cure for ALS
The UK government has recently announced that £50 million will be invested…
A road map for digital health care technology in MND
A road map for digital health care technology in MND
The COVID-19 pandemic has had an important impact on the development and…
Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Today, Amylyx Pharmaceuticals provided an update on its plans to advance its…
Newsletter December 2020
Newsletter December 2020
2020 has been a difficult year for everyone. However, despite the many…